FDA advisers vote against first MDMA therapy to treat PTSD
Jun 4, 2024 · MDMA is in a class of psychoactive drugs that produce experiences of emotional communion, relatedness and emotional openness. A federal advisory committee on Tuesday voted overwhelmingly against of...
FDA declines to approve novel MDMA therapy to treat PTSD, with ... - CNN
Aug 9, 2024 · The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news...
FDA panel rejects first MDMA treatment amid deep concerns ... - NBC News
Jun 4, 2024 · A Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA, commonly known as ecstasy or molly, as a treatment for post-traumatic stress disorder, a...
FDA rejects MDMA, disappointing drugmaker Lykos and psychedelics ... - NPR
Aug 9, 2024 · On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD at this time. Instead,...
FDA advisers reject MDMA as treatment for PTSD : Shots - Health News - NPR
Jun 5, 2024 · A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show...
FDA rejection of MDMA-assisted therapy rattles advocates but ... - CNN
Aug 13, 2024 · On Friday, the FDA declined to approve the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news release from drug sponsor Lykos ...
Lykos still plotting path to approval for rejected MDMA therapy
1 day ago · Lykos accepts FDA’s view that reviving rejected MDMA therapy’s fortunes requires fresh phase 3 trial The meeting with the FDA was designed to get feedback on the independent review plan Lykos ...
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Aug 9, 2024 · The Food and Drug Administration on Friday declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder, dealing a serious blow to the nascent field of...
FDA rejects MDMA-assisted therapy for PTSD - NBC News
The Food and Drug Administration declined to approve MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, drugmaker Lykos Therapeutics said Friday.
FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New York Times
Jun 4, 2024 · An independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday, highlighting the unparalleled regulatory...